Steward Partners Investment Advisory
VERA icon

Steward Partners Investment Advisory’s Vera Therapeutics VERA Stock Holding History

Steward Partners Investment Advisory’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.7K Buy
972
+600
+161% +$22.4K ﹤0.01% 3054
2026
Q1 		$15K Buy
372
+20
+6% +$862 ﹤0.01% 3371
2025
Q4 		$17.8K Buy
352
+2
+0.6% +$71 ﹤0.01% 3184
2025
Q3 		$10.2K Buy
+350
New +$8.09K ﹤0.01% 3399
2025
Q2 		– Sell
-350
Closed -$8.41K – 4249
2025
Q1 		$8.41K Hold
350
– – ﹤0.01% 3169
2024
Q4 		$14.8K Buy
+350
New +$15.5K ﹤0.01% 2928

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steward Partners Investment Advisory's VERA Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Vera Therapeutics (VERA) stake by 161% in Q2 2026, buying an estimated $22.4K and bringing the position to 972 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Steward Partners Investment Advisory first reported a position in VERA in Q4 2024 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Steward Partners Investment Advisory held 972 shares of Vera Therapeutics worth $41.7K as of Q2 2026.
  • Steward Partners Investment Advisory bought 600 Vera Therapeutics shares in Q2 2026, an estimated $22.4K.
  • Vera Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3054 holding.
  • Steward Partners Investment Advisory first reported a position in Vera Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.